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A combined computational and structural model
of the full-length human prolactin receptor
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The prolactin receptor is an archetype member of the class I cytokine receptor family,
comprising receptors with fundamental functions in biology as well as key drug targets.
Structurally, each of these receptors represent an intriguing diversity, providing an excep-
tionally challenging target for structural biology. Here, we access the molecular architecture
of the monomeric human prolactin receptor by combining experimental and computational
efforts. We solve the NMR structure of its transmembrane domain in micelles and collect
structural data on overlapping fragments of the receptor with small-angle X-ray scattering,
native mass spectrometry and NMR spectroscopy. Along with previously published data,
these are integrated by molecular modelling to generate a full receptor structure. The result
provides the ﬁrst full view of a class I cytokine receptor, exemplifying the architecture of more
than 40 different receptor chains, and reveals that the extracellular domain is merely the tip
of a molecular iceberg.
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T
he prolactin receptor (PRLR) and its primary ligand
prolactin (PRL) constitute a complex receptor system,
linked to more than 300 biological functions ranging from
reproduction and cell differentiation to immune responses1,2.
It is best known for its role in mammary gland development and
lactation3 as well as the pathology hyperprolactinemia4, but has
also been linked to reproductive disorders5 as well as breast6,7 and
prostate8 tumorigenesis, and has therefore attracted signiﬁcant
pharmaceutical interest.
The PRLR belongs to the hematopoietic cytokine receptor
superfamily, which consists of more than 40 members9. It is
considered an archetype of the homodimeric group 1 of
the family9, constituting the simplest cytokine receptors and
including, for example, the growth hormone receptor (GHR), the
erythropoietin receptor (EPOR) and the thrombopoietin
receptor9. All these receptors lack intrinsic kinase activity,
making them dependent on associated kinases such as the
Janus kinases (JAKs) to mediate signalling9. They are single-pass
transmembrane (TM) proteins with similar overall topologies: (1)
a folded extracellular domain (ECD) responsible for
ligand binding; (2) a TM domain (TMD) connecting the
extracellular- and intracellular parts and (3) an intrinsically
disordered intracellular domain (ICD) orchestrating down-
stream signalling9,10. Their ECDs fold into two ﬁbronectin
type III domains, named D1 (membrane-distal) and D2
(membrane-proximal). The latter contains a conserved
WS-motif11 that for the PRLR acts as a molecular switch
during activation12. The ICDs have low-sequence conservation,
except for two regions named Box1 and Box2. Box1 is a
membrane-proximal proline-rich motif responsible for
constitutive association of JAKs13, while the function of Box2
remains unclear, although some studies have suggested it to be
involved in JAK2 association13–15. Recently, studies have revealed
that homodimerization of group I cytokine receptors may occur
in the absence of hormone, and is insufﬁcient for receptor
activation16–18. Binding of a hormone to the ECDs leads to the
formation of an asymmetric ternary complex consisting of one
hormone and two receptor chains19–21.
Parts of the PRL/PRLR receptor system have been structurally
characterized including structures of the PRL22, the 1:1 and 1:2
complexes of PRL:PRLR-ECD16–18 and the unliganded human (h)
PRLR-ECD-D2 (ref. 12), as well as a recent characterization of the
hPRLR-ICD as being intrinsically disordered throughout its
length10. However, despite substantial efforts, important
structural and functional aspects of the PRLR remain
uncharacterized. As no structure is available of neither the
unliganded PRLR-ECD nor of the TMD, the overall structure
and mechanism of signal transfer remains elusive. Signal
transduction across the membrane following hormone binding is
suggested to occur by subunit rearrangements or propagation of
local structural changes, providing the TMDs with a key role.
Furthermore, it has been shown for several class 1 cytokine
receptors that the ligand-independent homodimerization takes
place in the TMDs16–18. Despite these signiﬁcant roles, the TMDs
remain largely understudied, although cellular reports on their
characteristics and roles in signal transduction are now emerging.
A recent study of the GHR proposed a model for signal
transduction where the homodimer TMD conformation switches
upon receptor activation from a parallel to a left-hand crossover
structure, thereby separating the TMDs at the C-terminal end and
eventually bringing the two JAK2s into productive positions17.
However, analogous alanine-insertion studies of the GHR23 and
the PRLR24 suggested that the activation mechanism of the two
related receptors differs in a poorly understood manner.
Although high-resolution structures of multi-pass trans-
membrane proteins in connection with extra-membranous
globular domains have been solved (for example, refs 25,26), no
such structures are available of single-pass transmembrane
proteins, which have fewer stabilizing contacts in their
membrane-embedded region. The structural characterization of
the full PRLR is further hampered by the challenges associated
with studies of a protein consisting of three structurally diverse
domains: a soluble, folded domain, a membrane-embedded
domain and an intrinsically disordered domain. Currently, no
single high-resolution method is capable of describing the
structural characteristics of a protein of this size and
complexity. To overcome these inherent limitations in sample
preparation and individual structure-determination techniques,
we here apply a multidisciplinary divide-and-conquer approach
in which we combine data acquired with different techniques on
overlapping domain variants of the hPRLR with molecular
modelling. In the centre of this endeavour lies the determination
of the hPRLR-TMD structure, which we here solve in
1,2-dihexanoyl-sn-glycero-phosphocholine (DHPC) micelles
using nuclear magnetic resonance (NMR) spectroscopy.
Combining this with previously published and new biophysical
data of the soluble domains, we generate a structural model of the
monomeric hPRLR, suggested to represent up to 70% of the
PRLRs in the cell membrane15. This hPRLR structure provides
the ﬁrst full molecular architecture of a class I cytokine receptor,
exemplifying more than 40 different receptor chains, and reveals
that the extracellular domain is merely the tip of a molecular
iceberg.
Results
Structure of hPRLR-TMD in micelles. As the missing piece in
the structural description of the hPRLR, we determined the
structure of the TMD in a membrane-mimicking environment
using solution state NMR spectroscopy. To ensure overlap with
previously determined structures, we used a hPRLR-TMD
construct with a ﬁve-residue overlap between hPRLR-D2 (ref. 12)
and hPRLR-TMD in its N-terminus (F206-D210), and a
ﬁve-residue overlap with hPRLR-ICD10 in its C-terminus
(G236-V240). The resulting 37-residue hPRLR-TMD harboured
residues F206-V240, as well as an N-terminal G-S sequence.
hPRLR-TMD was expressed and fast-track puriﬁed to 495%
purity (Supplementary Fig. 1) using a novel method27 and
screened for suitable detergents and temperatures for the
structural studies (Supplementary Fig. 2). A high concentration
of DHPC (TMD:DHPC 1:700) at 37 C provided narrow
linewidths and the expected number of peaks and hence was
selected for the structural studies. An SDS-PAGE of hPRLR-TMD
(Supplementary Fig. 1) revealed a clear monomer band below
14 kDa, with a faint dimer band just above 14 kDa. The deviation
from the average molecular weight of hPRLR-TMD (3,959.78Da)
can be explained by the commonly encountered gel-shifting
phenomenon observed for membrane proteins28. The oligomeric
state of hPRLR-TMD reconstituted in DHPC (1:700) was further
evaluated by native mass spectrometry, which is sensitive to
oligomerization of membrane proteins29 (Fig. 1a). The peaks
identiﬁed at 1,980.56m/z in the þ 2 charge state and at
3,958.16m/z in the þ 1 charge state are consistent with the
average molecular weight of one monomer (3,959.78Da). No
peaks representing higher oligomers of hPRLR-TMD were
observed. Thus, hPRLR-TMD appeared monomeric under these
conditions.
We proceeded to assign the chemical shifts of hPRLR-TMD in
DHPC micelles by standard heteronuclear NMR methods.
Manual assignments resulted in 99.0% completeness for backbone
15N, 13C and 1H resonances, and 90.3% for side chain proton
resonances. The secondary structure was evaluated by secondary
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chemical shift (SCS) values of Ca, Cb, C0 and Ha calculated from
published random coil values30, and with the motif identiﬁcation
from chemical shifts (MICS) programme31 using Ca, Cb, C0, NH,
HN and Ha chemical shifts. Together these analyses suggested
a-helical conformation for residues D210-A233 (Supplementary
Figs 3a and 4a), additionally supported by diagnostic a-helical
nuclear Overhauser effects (NOEs) (Supplementary Fig. 3a). The
SCSs further suggested that residues L234–G236 continued in a
transient a-helical turn (Supplementary Figs 3a and 4a). The
SCSs and NOE patterns of residues F206–N209 and Y237–V240
did not support highly populated secondary structures for these
residues. Analysis of possible N- and C-terminal a-helical
capping (N-cap and C-cap) motifs using MICS (Supplementary
Fig. 4c,d) suggested N209 or D210 (0.114 and 0.118, respectively)
to potentially form transient N-cap structures.
The above results were supported by 15N-T2-relaxation times
measured on hPRLR-TMD in DHPC micelles (Supplementary
Fig. 3c). Little variation was observed in backbone dynamics for
residues T212–L234 with 15N-T2-relaxation times just below
50ms. Towards the N- and C-terminus, the relaxation times
gradually increased, suggesting faster dynamics and correlating
well with the lack of secondary structure in these regions. Similar
relaxation measurements conducted on hPRLR-ICDG236–Q396
(including residues S238–V240 of hPRLR-TMD) (Fig. 2a–c)
supported these ﬁndings and further showed fast backbone
dynamics of the ICD.
The structure of hPRLR-TMD in DHPC micelles was
determined using 754 NMR-derived restraints (Table 1),
including short- and medium-range NOE-, dihedral angle- and
hydrogen bonding restraints (Supplementary Fig. 3a,b). Dihedral
angle restraints were estimated by TALOS32 and f-angles further
reﬁned from 3J(HN–Ha) coupling constants33 (Supplementary
Fig. 3b). We used the presence of small coupling constants
and characteristic a-helical NOE patterns as basis for
including hydrogen bonds between Hi(N) and (C)Oi-4 as
restraints (Supplementary Fig. 3b, grey circles). A ﬁnal set of
200 structures was calculated with Aria/crystallography & NMR
system (CNS),34,35 and the 10 structures with the lowest energy
conformations and without signiﬁcant violations were selected to
represent the structure of the monomeric hPRLR-TMD (Fig. 1c,d
and Table 1). The lowest energy structure formed a single a-helix
from residues D210–A233 (Fig. 1e) with a length of 36Å and two
symmetrically placed tryptophans pointing in opposite directions
on each side of the a-helix (Fig. 1g). A slight bend around S221
was observed, with a bending angle of 6. The a-helix contained
mainly hydrophobic residues, but harboured a few residues in the
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Figure 1 | Structure of hPRLR-TMD in DHPC micelles. (a) Native mass spectrum of hPRLR-TMD in 700 molar excess of DHPC. The peaks at
1,980.56m/z (þ 2) and 3,958.16m/z (þ 1) are consistent with one hPRLR-TMD monomer (3,959.78Da), while no peaks representing higher oligomers of
hPRLR-TMD were observed. (b) 1H-15N-HSQC spectrum of 1mM hPRLR-TMD in 700mM DHPC, 50mM NaCl, 20mM Na2HPO4/NaH2PO4, pH 7.2, 37 C.
Superimposition of the 10 lowest energy hPRLR-TMD structures in (c) stick and (d) ribbon representations. (e) Lowest energy structure of hPRLR-TMD in
DHPC micelles with backbone atoms in cartoon representation. The DHPC embedded region is shown in purple. (f) Cartoon representation of hPRLR-TMD
with polar side chains shown as sticks. (g) Top view of hPRLR-TMD highlighting the two symmetrically placed tryptophans.
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N-terminal part with side chains capable of forming hydrogen
bonds: S216, S221 and C225 (Fig. 1f). S221 and C225 were located
on the same side of the helix, while S216 was located half a turn
away (Fig. 1f).
Envelope structure of the unliganded hPRLR-ECD. To generate
a full structural model of the monomeric hPRLR, we needed a
representation of the unliganded ECD. However, all known
structures of the PRLR-ECD are crystal structures solved
in complex with PRL, placental lactogen or PRL-based
antagonists19,20,36–38. We previously attempted to solve the
structure of the unliganded hPRLR-ECD in solution, but found
it incompatible with acquisition of high-quality NMR data12.
Instead, the structure of hPRLR-ECD-D2 was solved, revealing
that the overall conformation of the unliganded
ECD-D2 was similar to that of the liganded state, but with
signiﬁcant local differences in strand length and in the
WS-motif12. Thus, to obtain structural information on the full
ECD in the unliganded state, we measured solution small-angle
X-ray scattering (SAXS) proﬁles of the unliganded hPRLR-ECD,
shown to be monomeric by size-exclusion chromatography22
(Figs 3b and 4b). The resulting SAXS curve was ﬁtted to the
coordinates of a liganded hPRLR-ECD structure37 using
CRYSOL39. The theoretical scattering curve of this ECD
model ﬁts in detail with the experimentally determined
envelope (w2¼ 1.2) and a pseudo-atom model was constructed
using DAMMIN (Fig. 3a,b). The angle between D1 and D2 in the
ECD model was, within the resolution measurable by SAXS
analysis, similar to both the liganded and unliganded GHR and
EPOR structures (PDB entries 2AEW, 1A22, 1ERN and 4Y5Y).
Together these ﬁndings suggested that no substantial structural
rearrangement occurs upon ligand binding to hPRLR-ECD, and
provided a model of the unliganded hPRLR-ECD.
Ensemble description of the hPRLR-ICD. We recently showed
the long-form hPRLR-ICD to be intrinsically disordered with ﬁve
transiently populated a-helices10. Here, by NMR, we further
investigated the intrinsic propensity of the ICD to homodimerize
and found no evidence to support dimerization of the unmodiﬁed
ICD chain (Fig. 2d). Thus, we used Flexible Meccano40 (FM) to
generate a model of the hPRLR-ICDG236–H598 as an ensemble of
monomeric, rapidly inter-converting conformers. For validation
purposes, NMR diffusion experiments were applied to measure
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Figure 2 | Intrinsic structural properties of hPRLR-ICD. (a) T1- and (b) T2-relaxation times for hPRLR-ICDG236–Q396 backbone amides plotted against
residue number. (c) T2/T1 for hPRLR-ICDG236–Q396 backbone amides plotted against residue number. The vertical black lines represent the estimated error
of each ﬁt. ‘*’ indicates residues for which the relaxation time was not determined. (d) Concentration dependence of the spectral properties of
hPRLR-ICDG236–H598. Overlay of
1H-15N-HSQC spectra of 20mM (red) and 400mM (black) hPRLR-ICDG236–H598. The spectra were recorded under identical
conditions, except that the low-concentration sample was recorded with 152 transients, while the high concentration was recorded with 16. No changes in
chemical shifts were detected as a consequence of the 20 times dilution, highlighting the monomeric properties of hPRLR-ICDG236–H598.
Table 1 | NMR restraints per structure and statistics for the
hPRLR-TMD structure ensemble.
hPRLR-TMD
NMR distance and dihedral constraints
Distance constraints
Total NOE 677
Intra-residue 396
Inter-residue 281
Sequential (|i j|¼ 1) 139
Medium-range (|i j|o4) 142
Long-range (|i j|45) 0
Intermolecular 0
Hydrogen bonds 13
Total dihedral angle restraints
f 47
c 26
Structure statistics*
Violations (mean and s.d.)
Distance constraints (Å) 0.020þ /0.002
Dihedral angle constraints () 1.84þ /0.001
Max. dihedral angle violation () 5.00
Max. distance constraint violation (Å) 0.301
Deviations from idealized geometry
Bond lengths (Å) 0.002þ /0.000
Bond angles () 0.368þ /0.004
Impropers () 0.298þ /0.009
Average pairwise r.m.s. deviationw (Å)
Heavy 0.40þ /0.09
Backbone 0.30þ /0.11
*Statistics were calculated and averaged over an ensemble of the 10 lowest energy structures
out of 200 calculated structures.
wPairwise r.m.s. deviation was calculated among 10 structures, and includes only the structured
region of the protein.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11578
4 NATURE COMMUNICATIONS | 7:11578 | DOI: 10.1038/ncomms11578 | www.nature.com/naturecommunications
the hydrodynamic radius (RH) of hPRLR-ICD to 74Å±1Å
(Fig. 4e). The calculated average RH of the FM ensemble was
58±6Å, suggesting it to be slightly more compact than proposed
by the experimentally determined RH (discussed below).
Membrane embedment and interactions. Although the TMD is
presumed to be the only truly membrane-embedded part of the
hPRLR, the ECD and the ICD are tethered by the TMD to the
outer or inner leaﬂets of the lipid bilayer, respectively. Potential
interactions between the hPRLR and the membrane bilayer
should therefore not be ignored. We recently established that
hPRLR-ICD interacts with lipids characteristic of the inner
membrane leaﬂet10, but it is unknown if—and to what extent—
the ECD interacts with the membrane as suggested from
theoretical considerations41.
Using an analogous approach as for hPRLR-ICD10, putative
interactions between hPRLR-D2 and 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC), the most abundant lipid
of the mammalian outer membrane42, were probed using NMR
by titrating small-unilamellar vesicles (SUVs) into a solution of
15N-hPRLR-ECD-D2. However, in contrast to the ICD, we
observed no effect on the chemical shifts or peak intensities on
addition of 16 molar excess of POPC (Fig. 4a), suggesting no
signiﬁcant afﬁnity between the ECD-D2 and the major lipid
constituent of the membrane bilayer.
Embedment of hPRLR-TMD in DHPC was examined with a
series of experiments. First, the proximity and interaction
between water and backbone amides were investigated using
amide–water NOEs (Supplementary Fig. 5a). Not surprisingly,
NOEs were readily detected between water and the amides in the
ﬂexible N- and C-terminal regions (F206-D210, K235-V240),
whereas no detectable NOEs were identiﬁed from the majority of
the amides in the TMD a-helix. However, we did observe NOEs
between water and the amides of T212, V213, S216, V217 and
S221, some of which are positioned close to the centre of the
TMD. However, these NOE peaks could originate from the
proximate hydroxyls of T212, S216 and S221. To further
understand the TMD embedment, we therefore performed
hydrogen–deuterium (H–D) exchange experiments at different
levels of D2O following establishment of a quasi-stationary state
(Supplementary Figs 5b and 6). These data supported the pattern
revealed from the amide–water NOE data, suggesting some
degree of water contact at the N-terminal part of the a-helix,
potentially explained by this being more polar than the
C-terminal (Supplementary Fig. 5c). The chemical shifts, NOEs,
coupling constants and 15N-T2-relaxation times clearly
established structure in the N-terminal end of the a-helix. Thus,
the non-uniform exchange pattern and the water NOEs are likely
not a result of extreme dynamics, but instead of the N-terminal
polarity in combination with the properties of the detergent.
DHPC is, as a short-tail version of POPC, in theory only
capable of assembling a B16Å wide hydrocarbon bilayer43,
compared to the 29Å of a POPC bilayer44, rendering a spherical
micelle-embedment model unlikely. Thus, in light of the above
data, it seems likely that DHPC patches the TMD surface with a
prolate ellipsoid monolayer (Supplementary Fig. 5d) as suggested
also for the OmpX43. Despite this, the hPRLR-TMD region
embedded in DHPC ﬁts remarkably well with the region
predicted to be within the native bilayer (T211–L234)45,
possibly caused by anchoring at two charged residues; D210
and K235. Hence, even with the shortcomings of DHPC, the data
collectively suggest that the membrane embedment range was
well-simulated and constituted T211–L234.
In conclusion, the ICD has previously been shown to interact
with membrane bilayer constituents, whereas the ECD-D2
appears intrinsically void of signiﬁcant afﬁnity for POPC.
The data collectively supported that T211–L234 of the TMD
were embedded in the membrane mimetics, while the
extracellular F206–D210 and intracellular K235–V240 protruded
at each end.
Data integration to generate a full structural model. We
combined the experimentally based ensemble of the ICD and the
unliganded ECD with the structure of the TMD to generate a
complete structural model of the hPRLR (Fig. 4). The overlapping
region between the hPRLR-ECD and hPRLR-TMD (F206-D210)
formed little regular structure, as evidenced by the SCSs from the
solution structure of the ECD-D2 (ref. 12), and the coupling
constants, relaxation rates and SCSs of the TMD (Supplementary
Fig. 3a–c). Thus, residues P203–N209 most likely constitute a
linker region without regular secondary structure between
b-strand G of the ECD-D2 and the TMD a-helix, which we term
juxtamembrane-linker 1 (JML1). Proceeding the TMD helix,
L234–G236 continued in a transient helical turn, while we
observed no regular secondary structure in the overlap region
between the TMD and the ICD (G236–V240) neither in the data
from this study (Supplementary Fig. 3a–c and Fig. 2a) nor from
the previous characterization of the ICD10. We thus refer to
residues Y237–C242 as juxtamembrane-linker 2 (JML2). Hence,
we ﬁnd that the overlap regions between the three isolated
domains lacked regular secondary structure and therefore were
suitable as assembly sites. We oriented the ECD perpendicular to
the membrane surface, as no interactions between hPRLR-ECD-
D2 and POPC were observed (Fig. 4a), while the TMD was
oriented in accordance with the DHPC-embedment data
presented above.
The resulting structure of the monomeric hPRLR provides the
ﬁrst view of the molecular architecture of a full class I cytokine
receptor (Figs 4 and 5). Moving from N- to C-terminus, it
consists of the ECD (Q1-I202), JML1 (P203-N209), TMD (D210-
G236), JML2 (Y237-C242) and ICD (I243-H598). The hPRLR
structure isB345Å on the vertical axis from N to C terminus, of
which the ECD constitute B20%, the TMD B10% and the ICD
B70%.
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Figure 3 | Monomeric, unliganded hPRLR-ECD envelope generated from
SAXS data. (a) Superimposition of the SAXS ECD envelope (mesh) and a
crystal structure of the liganded hPRLR-ECD (PDB entry 3D48, b-sheets are
blue, a-helices are red, loops are grey) generated with UCSF CHIMERA66.
(b) Pair distance distribution function of the SAXS data collected on the
unliganded, monomeric ECD.
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Discussion
In this work we have presented a structural model of the
unliganded, monomeric hPRLR-ECD generated from SAXS data.
The structure of the liganded ECD37 ﬁts in detail into the
unliganded ECD SAXS envelope, revealing that the relative
orientation of D1 and D2 is preserved (Fig. 3a). Thus, in line with
ﬁndings of time-resolved Fo¨rster resonance energy transfer
(FRET) studies46, no substantial conformational changes appear
to take place in the PRLR-ECD upon hormone binding. This
observation is consistent with ﬁndings for the GHR; the crystal
structure of the unliganded GHR-ECD23 shows only minor
changes compared to the ligand bound state, pointing towards a
signal transduction mechanism that rely on subunit reorientation,
as suggested for the GHR17. However, there are also studies
pointing at differences in the signal transduction mechanism
between the GHR and the PRLR. For example, although the ICDs
of the receptors share properties such as intrinsic disorder and
conserved motifs (Box1 and Box2), they also display interesting
differences in their pattern of transient structures and number
and position of lipid interaction domains (LIDs)10. Further, in
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corresponding ﬁt (red).
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alanine-insertion studies of the GHR23 and the PRLR24,
insertions in the JML2 of the GHR affected receptor activity23,
while analogous insertions in the PRLR had no effect24. For the
JMLs to function as hinges in the subunit reorientation
mechanism they need to have some degree of rigidity. The lack
of effect on insertions in the hPRLR-JML2 may be understood
from the structural model presented here and previously
published data10, showing that the hPRLR-JML2 is without
rigid structure, whereas the corresponding region in the GHR
showed propensity for transient a-helical structures. Thus, if
JML2 in the PRLR should function as a hinge during activation,
the required rigidity must be imposed by other components than
the intrinsic structure alone. Overall, these ﬁndings suggest that
the PRLR and the GHR may share similar activation mechanisms
on the extracellular side of the receptor, but vary intracellularly in
line with their different biological functions.
The structure of the monomeric hPRLR-TMD presented in
this work revealed the extent of the a-helical secondary structure
and a characteristic tryptophan symmetry. Tryptophans are
preferably positioned towards the ends of bitropic TMD
a-helices47, receive the greatest energy reward for partitioning
into the lipid head group region48, and may act as interfacial
anchors that regulate the helix tilt angle49. The placement of
W214 and W230 in the second helix turn from the N- and C-
termini of the TMD, respectively, ﬁts well with a role of these in
membrane anchoring. If the PRLR exerts its functions through a
similar mechanism as suggested for the GHR17, the hPRLR-TMD
should be able to switch between two different dimer
conformations corresponding to the inactive and active states.
With this in mind, W214 and W230 may be important not only
in terms of controlling the crossing angle of the lowest energy
monomer and dimer, but also in rendering a second dimerization
interface, with a different crossing angle, less favourable.
Although the TMDs of class I cytokine receptors have been
shown to be responsible for receptor homodimerization16–18,
no classical dimerization motifs50 are present in the hPRLR-TMD
and the monomeric form was readily obtained in this work even
at high concentrations. Thus, hPRLR-TMD206–240 appears to have
a weak inherent propensity to homodimerize. In fact, the lack of
classical dimerization motifs is shared by the related
hEPOR-TMD, and its structures have also only been solved in
monomeric forms51,52. This weak inherent dimerization
propensity suggests that other components than those of the
hPRLR-TMD206–240/DHPC system may be important to drive
TMD dimerization. Potential factors include the adjacent
domains, membrane interaction partners such as speciﬁc lipid
components (for example, phosphoinositides, cholesterols etc.) or
accessory bound proteins (for example, JAK2). The polar residues
in the core of the hPRLR-TMD a-helix (S216, S221 and C225) may
be of possible relevance to homodimerization. In TMDs, such side
chains are often involved in inter-monomeric hydrogen bonds,
improving the stability and speciﬁcity of a-helical associations with
one of the most common participants being serine53. Interestingly,
the least common amino acid type in TM regions is cysteine54,
suggesting that C225, placed deep within the TMD, might play a
special role. A cellular mutagenesis study on the hPRLR has shown
that substituting C225 with a serine decreased ligand-independent
dimerization byB30% (ref. 18), suggesting that C225 takes part in
TMD dimerization, without being vital. In hPRLR-TMD, S221 and
C225 are positioned in two adjacent a-helical turns, while S216 is
positioned half a turn away (Fig. 1f), suggesting that the hPRLR
has the potential to form two different dimerization interfaces
involving serines. These two could be interchangeable through
rotation of the TMDs during receptor activation, perhaps with
C225 as pivot point.
The structures of the monomeric TMDs from the related
human and mouse (m) EPOR were recently solved in
n-dodecylphosphocholine (DPC) micelles on the basis of dihedral
angles obtained from TALOS using Ca chemical shifts only, a
modest number of NOEs and backbone hydrogen bond
restraints51,52. Due to a lack of restraints on the side chains of
these structures, we regard them mainly as backbone structures,
represented by a straight a-helix spanning residues L226-W258
for both species. Surprisingly, these a-helices continue nine
residues into the JM-region without any apparent ﬂexibility,
having important implications for the mode of hormone-binding-
induced signal propagation from the TMD to Box1. We note that
no non-sequential NOEs for H249-L253 (hEPOR-TMD) or
around H249 (mEPOR-TMD) or other data appear to support
this a-helix extension51,52. In contrast, relaxation data for
both EPOR-TMDs reveal increased internal dynamics from
H249–P254, supporting a less-structured conformation not
captured by the structures51,52. Thus, if these regions instead
are interpreted as forming transient helical structures, these
related structures have a similar overall topology as hPRLR-TMD.
Inherent limitations in sample preparation and individual
techniques for structure determination make atomic-resolution
studies of the structurally diverse hPRLR challenging. We
therefore applied an approach in which data were integrated
from multiple structural disciplines combining new SAXS, MS
Box2 Box1
FERM-SH2
LID1
LID2
LID3
WSXWS
Figure 5 | Molecular architecture of the hPRLR with important regions highlighted. The full hPRLR structural model is shown as spheres from two
different angles, with the ICD represented by 1 out of the 1,000 models. The membrane-embedded part of the receptor is coloured pink, while the
water-soluble domains are blue. The WSXWS motif is shown in mint green, Box1 and Box2 are orange and the three LIDs are green. For size comparison,
the FERM-SH2 domains from TYK2 (PDB entry 4PO6 (ref. 56)) are shown in grey.
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and NMR data with previously published data and molecular
modelling to acquire the molecular architecture of the full hPRLR
(Figs 4 and 5). This model provides the ﬁrst molecular
architecture of a full-length class I cytokine receptor, revealing
the relative sizes of the individual domains. The hPRLR model
consists of the soluble, globular ECD (Q1–I202), the unstructured
JML1 (P203–N209), the membrane-embedded TMD (D210–
G236), the unstructured JML2 (Y237–C242) and the intrinsically
disordered ICD (I243–H598). The ICD was in a previous study
shown to contain ﬁve transient a-helices (Fig. 4, red stretches)
and three non-cooperative LIDs along the chain10, which have
not been directly included in the model, but are shown in Fig. 5
(green).
The full hPRLR structure reveals that the ECD, which until
recently was the only structurally characterized part of the class I
cytokine receptors, merely constitutes the tip of an extensive
molecular iceberg. Previously, visualizations of this receptor
family have typically shown a disproportionally dominating ECD
compared to the TMD and ICD, likely reﬂecting the overall
information content available for each domain. From our
structure it is now evident that the ICD is more than twice as
extended in the direction of the membrane normal compared to
the ECD and the TMD combined (Fig. 4). The structural
ﬂexibility and large capture radius of the ICD allows it to reach
and interact with a variety of interaction partners, possibly also
other receptors’ ICDs. Interaction sites in disordered regions
typically only constitute a few residues, so-called small linear
motifs (SLiMs), and hence the ICD is geared to simultaneously
interact with many kinases, phosphatases and other proteins.
Box1 is an example of such a SLiM in the PRLR-ICD, shown to
interact with JAK2 (ref. 13), most likely through its FERM (4.1,
Ezrin, Radixin, Moesin) domain55. To illustrate the relative sizes
of these proteins, Box1 along with the FERM-SH2 domains from
TYK2 (ref. 56), a JAK2 homologue, are highlighted in Fig. 5.
The generated ensemble model of the ICD represents its
unbound intrinsic structure, represented by an ensemble of 25
conformers in Fig. 4. However, in the cell the structural ensemble
of the ICD may be different in several ways. First, of all the three
LIDs10 have not been restricted to interact with the membrane in
this model. Since experimental measurements of the RH in the
presence of SUVs would be dominated by signals from the SUVs,
this was not attempted, but it is likely that the LID-mediated
membrane contacts would result in a smaller RH of the ICD.
Thus, we regard the experimentally determined RH obtained in
the absence of SUVs as an upper limit capture radius for the ICD.
Second, constitutively bound kinases have deliberately been
omitted, primarily because their mutual binding sites have not
been adequately described, if at all known. Last, post-translational
modiﬁcations of the ICD, in particular phosphorylations, may
have the potential to change the structural ensemble of the ICD57
and thus its compactness. Importantly, there are no indications to
suggest the ICD to be folded, and the ICD does not intrinsically
dimerize (Fig. 2d). Hence, other proteins or modiﬁcations such as
acetylation and phosphorylations would be needed to promote
ICD dimerization, in essence completely analogous to the
hormone-induced dimerization of the ECD-D2 domains.
The presented structural model of the hPRLR provides
important new insights on the full structure of class I cytokine
receptors, and provides a framework for understanding the
mechanisms related to these receptors, as for example, derived
from cellular studies. However, being based on a divide-
and-conquer approach, it still poses unresolved questions.
First, due to the methodological restrictions on structural
characterization of a PRLR variant that includes both the ECD
and TMD, the exact relative orientation of these domains remains
unestablished. However, in the alanine-insertion study by Liu and
Brooks24, insertions in PRLR-JML1 did not affect receptor
functionality, suggesting that the relative orientation between
the ECD and the TMD is not essential. Second, it calls for
reservations that the TMD structure was solved in detergent
rather than a bilayer. Consequently, the angle between the
TMD and the bilayer plane (helix tilt angle) remains speculative.
Furthermore, although the structural envelope was obtained
in the present work and the unliganded ECD-D2 structure is
available12, a high-resolution structure of the unliganded ECD
is missing. Last, the model does not include any potential
interactions with the glycosaminoglycan layer, suggested to
implicate the WS-motif11, or effects from post-translational
modiﬁcations.
In conclusion, our head to toe structural model of the hPRLR
provides a starting point for future reﬁnements and may
help design strategies for novel structural and functional studies.
Importantly, it exempliﬁes the architecture of the many
biologically fundamental receptors of the class 1 cytokine receptor
family, and speciﬁes a scaffold onto which a new view on cellular
signalling can be built.
Methods
Materials. DHPC, DPC, 1-myristoyl-2-hydroxy-sn-glycero-3-phospho-(10-rac-
glycerol) (LMPG), 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(10-rac-glycerol)
(LPPG), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-
3-phospho-L-serine (sodium salt) (POPS) were purchased from Avanti Polar Lipids
(Alabaster, AL). 2,2-didecylpropane-1,3-bis-b-D-maltopyranoside (MNG-3) and
Amphipol A8–35 were purchased from Anatrace (Maumee, OH). 1,1,1,3,3,3-
Hexaﬂuoro-2-propanol (HFIP) and N-lauroylsarcosine sodium salt (sarkosyl) were
purchased from Sigma-Aldrich (St Louis, MO). Sodium dodecyl sulphate (SDS) was
purchased from Avantor Performance Materials (Deventer, NL). Dihexanoyl-d22-
phosphatidylcholine-d9 (d9DHPC) was purchased from FB Reagents (Boston, MA).
Protein expression and puriﬁcation. Complementary DNA encoding the
full-length long isoform of the human PRLR was ampliﬁed from
IRAKp961G13133Q (RZPD German Resource Center for Genome Research).
A detailed description of the expression and puriﬁcation of hPRLR-D2M99–D210
can be found in ref. 12, but in brief, the sequence of hPRLR-D2 (M99-D210) was
sub-cloned into a pET11a vector (Novagen), transformed into competent E. coli
BL21(DE3) cells, and expressed in 15N-labelled M9-media (3 g per l KH2PO4,
7.5 g l 1 Na2HPO4 H2O, 5 g l 1 NaCl, 1mM MgSO4, 1ml M2 trace solution,
4 g l 1 glucose, 1.5 g l 1 (15NH4)2SO4, (ISOTEC)) added 100 mgml 1 ampicillin.
Following collection, cells were resuspended and sonicated on ice to bring
hPRLR-D2 in solution. After ammonium sulphate (AMS) precipitation (75% (w/v),
stirring for 2 h at 0 C), the precipitate was dissolved in 30mM NH4HCO3,
100mM NaCl and 1mM dithiothreitol (DTT) (pH 8.0) and applied to a Sephadex
G50-Fine (GE Healthcare) column (24 370mm, 167ml). hPRLR-D2 fractions
were pooled, concentrated and buffer exchanged.
The sequence of hPRLR-ECD (Q1-D210) was sub-cloned into a pET11a vector
(Novagen), transformed into competent E. coli BL21(DE3) cells, and grown in LB
media (10 g per l peptone, 5 g l 1 yeast extract, 10 g l 1 NaCl, pH 7.4) at 37 C and
180 r.p.m. Cells were induced at OD600¼ 0.8 with 1mM isopropyl b-D-1-
thiogalactopyranoside for 4 h and subsequently collected by centrifugation (5,000g,
15min, 4 C). The cell pellet was resuspended in lysis buffer (40ml l 1 culture 25%
(w/v) sucrose, 5mM EDTA, 1 PBS buffer (pH 7.4), 1% (w/v) Triton X-100),
sonicated on ice (2 3min with 3min rest between rounds at 50% amplitude), and
the inclusion bodies (IBs) collected by centrifugation (20,000g, 25min, 4 C). This
cycle was repeated a total of three times. The IBs were denatured in 6M Urea,
10mM b-mercaptoethanol, 50mM Tris–HCl (pH 9.0), followed by refolding by
simple dialysis into 50mM Tris–HCl (pH 9.0), 150mM NaCl, 10mM cysteamin,
1mM cystamin (3 4 l), protein concentration o0.1mgml 1. The refolded
fraction was precipitated by addition of AMS to 75% (w/v), and left for 2 h with
gentle stirring at room temperature. The precipitate was dissolved in MilliQ water
and gel-ﬁltered on a Sephadex G50-Fine column (24 370mm, 167ml)
(GE Healthcare) in 0.1M NaCl, 1mM DTT, 30mM NH4HCO3 (pH 9.0). Peak
fractions were dialyzed against 10mM Na2HPO4 (pH 7.4).
A detailed description of the expression and puriﬁcation of hPRLR-TMDF206–V240
can be found in ref. 10, but in brief, the sequence of hPRLR-TMD (F206–V240) was
sub-cloned into a pGEX-4T-1 vector (Amersham, GE Healthcare), containing an
N-terminal glutathione S-transferase-carrier protein and a thrombin cleavage site.
The plasmid DNA was transformed into competent E. coli BL21(DE3) cells and
expressed in either unlabelled, 15N or 13C-, 15N-labelled M9 media (if 13C-labelled:
13C-D-Glucose, ISOTEC, if 15N-labelled: (15NH4)2SO4, ISOTEC) added 100mgml 1
ampicillin. The collected cells were resuspended in lysis buffer (40ml l 1 culture
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25% (w/v) sucrose, 5mM EDTA, 1 PBS buffer (pH 7.4), 1mM PMSF), and
sonicated on ice. Subsequently the IBs were collected by centrifugation (20,000g,
25min, 4 C). This cycle of resuspension, sonication and centrifugation was repeated
three times. The resulting IBs were resuspended in 50mM Tris–HCl buffer, collected
by centrifugation (20,000g, 20min, 4 C), solubilized in 12ml (per l culture) 1.5% (w/
v) sarkosyl, 100mM DTT, 20mM Tris–HCl buffer (pH 7.4) and incubated at room
temperature with gentle agitation for 3 h. Insoluble material was removed by
centrifugation (12,000g, 20min, 4 C). The supernatant was dialyzed against 0.5% (w/
v) sarkosyl, 10mM NaCl, 50mM Tris–HCl buffer (pH 7.4) to remove DTT and
cleaved with thrombin to release the glutathione S-transferase carrier protein. After
cleavage the solution was lyophilized, followed by resuspension in milliQ water
(200ml ml 1 of original solution). This solution was divided into batches of 50ml,
each of which was added to 750ml of a 1:2 chloroform:methanol solution and mixed
well. The solution was centrifuged (14,000g, 2min, 4 C), resulting in separation in
three layers. The top aqueous layer was carefully removed. Subsequently, 500ml of
MeOH was added to the remaining solution, followed by thorough mixing. The
mixture was incubated on ice for 20min, followed by centrifugation (16,000g, 40min,
4 C). The supernatant containing the target protein was transferred to a glass vial,
and the organic solvent evaporated under a stream of N2.
A detailed description of the expression and puriﬁcation of hPRLR-ICDG236–H598
and hPRLR-ICDG236–Q396 may be found in ref. 27, but in brief, G236–H598 and
G236–Q396 of hPRLR were sub-cloned into pET11a vectors (Novagen). The
plasmids were transformed into competent E. coli BL21(DE3) cells and protein
expressed in either unlabelled, 15N or 13C-, 15N-labelled M9 media added
100mgml 1 ampicillin. Cells were collected by centrifugation (20min, 5,000g, 4 C)
and stored at  20 C until thawed on ice and resuspended in 40ml sonication
buffer (20mM Na2HPO4/NaH2PO4 pH 8, 300mM NaCl, 0.08% (w/v) Triton X-100
and one complete EDTA-free protease inhibitor cocktail tablet (Roche Diagnostics
GmbH)). The cells were sonicated on ice (4 30 s with 30 s rest between rounds at
100% amplitude), centrifuged (25min, 20,000g, 4 C), and the supernatants used for
puriﬁcation.
After sonication the supernatant containing hPRLR-ICDG236–H598 was heated for
5min at 95 C, incubated on ice for 10min, and centrifuged to remove precipitate
(10min, 20,000g, 4 C). The supernatant containing hPRLR-ICDG236–H598 was added
10mM DTT, precipitated to 35% with AMS on ice, gently stirred and incubated on
ice for 2 h before centrifugation (20min, 20,000g, 4 C). The pellet was resuspended
in 20ml 20mM Tris–HCl (pH 8.0) and dialyzed against 1 l 20mM Tris–HCl
(pH 8.0) at 4 C before applying the sample to a 5ml HiTrap Q Sepharose Fast Flow
(QFF) (Amersham Bioscience) column pre-equilibrated with 5 column volumes
solution buffer (20mM Tris–HCl (pH 8.0), 0.1mM DTT). hPRLR-ICDG236–H598
was eluted over a linear gradient of 20 column volumes with elution buffer (20mM
Tris–HCl (pH 8.0), 1M NaCl, 0.1mM DTT).
In case of hPRLR-ICDG236–Q396, DNA was precipitated with a ﬁnal
concentration of 0.1 % (v/v) protamine sulphate added on ice, gently stirred and
incubated on ice for 10min before centrifugation (50min, 37,000g, 4 C). The
supernatant was heated for 5min at 95 C, incubated on ice for 10min, and
centrifuged to remove the precipitate (10min, 20,000g, 4 C). The supernatant
containing hPRLR-ICDG236–Q396 was precipitated to 35% with AMS on ice, gently
stirred and incubated on ice for 2 h before centrifugation (20min, 20,000g, 4 C).
The pellet was resuspended in 20ml 20mM Tris–HCl (pH 8.0) and dialyzed
against 1 l 20mM Tris–HCl (pH 8.0) at 4 C before applying the sample to a 5ml
HiTrap QFF column using a protocol similar to that of hPRLR-ICDG236–H598.
Screening of membrane mimetics. In case of SDS, DPC, SDS:DPC, sarkosyl,
DHPC, LMPG and LPPG B150 nmol 15N-hPRLR-TMD was reconstituted in the
membrane mimetics of choice in 50mM NaCl, 20mM Na2HPO4/NaH2PO4
(pH 7.2), followed by thorough buffer exchange in a  3 kDa cutoff spinﬁlter with
50mM NaCl, 20mM Na2HPO4/NaH2PO4 to remove residuals. When testing the
two amphipols A8–35 and MNG-3, 150 nmol 15N-hPRLR-TMD was solubilized in
0.3% (w/v) sarkosyl mixed with either 800 nmol MNG-3 or 600 nmol A8–35.
Sarkosyl was subsequently removed by thorough buffer exchange in a  3 kDa cutoff
spinﬁlter with 50mM NaCl, 20mM Na2HPO4/NaH2PO4 (pH 7.2). HFIP was tested
by adding 60% HFIP/40% H2O directly to B150 nmol 15N-hPRLR-TMD followed
by thorough mixing. DHPC/DMPC-, DHPC/POPC- and DHPC/POPC/POPS (3:1)
bicelles were prepared by solubilizing 15N-hPRLR-TMD in DHPC, followed by
thorough buffer exchange in a  3 kDa cutoff spinﬁlter with 50mM NaCl, 20mM
Na2HPO4/NaH2PO4. Subsequently, ((nDHPC nCMC)/0.3) mol solubilized lipids
were added to the 15N-hPRLR-TMD/DHPC mixture to give q¼ 0.3 (long-to-short-
chain lipid ratio). The TMD/DHPC/lipid mixtures were then subjected to
freeze/thaw cycles until the solution cleared. The samples were prepared at 5% or
15% (w/v) lipid content. All samples were added 10% (v/v) D2O, 2mM
tris(2-carboxyethyl)phosphine (TCEP), 1mM 2,2-dimethyl-2-silapentane-5-
sulphonic acid (DSS), 0.05% NaN3 and 50mM NaCl, 20mMNa2HPO4/NaH2PO4 to
a ﬁnal volume of 370ml followed by pH-adjustment to 7.2 before being transferred to
a Shigemi NMR tube. 1H-15N-HSQC spectra of hPRLR-TMD reconstituted in the
various membrane mimetics were recorded on a Varian INOVA 800-MHz (1H)
spectrometer at temperatures between 25 and 42 C.
Native mass spectrometry. A sample containing 25 mM hPRLR-TMD,
700 molar excess DHPC and 200mM ammonium acetate buffer was prepared
for native MS by extensive buffer exchange in  3 kDa spinﬁlter with 200mM
ammonium acetate buffer (pH 7). Samples were loaded into gold coated
nano-electrospray emitters prepared in-house as previously described58. A range of
dilutions (using milliQ water) were prepared for MS analysis, ranging from 10 to
100 mM, maintaining the 1:700 hPRLR-TMD:DHPC ratio.
NMR spectroscopy on hPRLR-TMD. All NMR spectra were recorded on Varian
INOVA 750- or 800-MHz (1H) spectrometers with room temperature probes or a
Bruker 900-MHz (1H) with a 5mM CPTCI probe. Free induction decays were
transformed and visualized in NMRPipe59 and analyzed using the CcpNmr
Analysis software60. Unless otherwise speciﬁed, all hPRLR-TMD samples were
recorded at 37 C and contained 10% (v/v) D2O, 4mM TCEP, 2mM DSS, 0.05%
(v/v) NaN3, 50mM NaCl and 20mM Na2HPO4/NaH2PO4 (pH 7.2). Proton
chemical shifts were referenced internally to DSS at 0.00 p.p.m., with heteronuclei
referenced by relative gyromagnetic ratios.
For assignments of backbone nuclei, heteronuclear NMR spectra were recorded
on a sample containing 0.8mM 13C-,15N-hPRLR-TMD in 560mM DHPC. Backbone
assignments were performed manually from the analyses of 1H-15N-HSQC,
HNCACB, CBCA(CO)NH and HNCO spectra acquired with non-uniform
sampling61. The backbone chemical shifts were used in TALOS32 to estimate the
dihedral angle restraints, and in the motif identiﬁcation from chemical shifts (MICS)
programme31 to identify possible motifs. NOE assignments were performed manually
from analysis of a 15N-NOESY-HSQC spectrum (mixing time of 100ms) and
13C-NOESY-HSQC spectra of the aliphatic region (mixing time of 150ms) and
the aromatic region (mixing time of 150ms), acquired on a sample containing 1mM
13C-,15N-hPRLR-TMD in 700mM d9DHPC.
A 3D HNHA spectrum33 was recorded on 0.7mM 15N-hPRLR-TMD in
490mM DHPC and 3J(HN-Ha) couplings constants were extracted from the
relative intensity of Ha and HN peaks using the CcpNmr Analysis software60.
The 3J(HN-Ha) coupling constants were utilized to estimate the backbone dihedral
f-angles from the Karplus relationship with coefﬁcient values of 6.51,  1.75 and
1.60 for A, B, and C, respectively33. For amides with coupling constants below
o5Hz along with NOE patterns characteristic of a-helical conformation,
hydrogen bond restraints were created between Hi(N) and (C)Oi-4.
A series of 1H-15N-HSQC spectra were recorded on a sample containing
0.7mM 15N-hPRLR-TMD in 490mM DHPC to analyze of the decay of the
transverse relaxation (T2). T2 relaxation times were calculated from standard
HSQC spectra recorded at 800MHz using seven different relaxation delays between
10 and 130ms. The relaxation decays were ﬁtted to single exponentials and
relaxation times calculated using the CcpNmr Analysis software60.
Hydrogen-to-deuterium (H–D) exchange experiments were performed on
samples containing 0.4mM 15N-hPRLR-TMD in 300mM DHPC on the basis of
the principles of Veglia et al.62 Samples were lyophilized followed by
resolubilization in 10, 30, 40, 50, 70 or 90% (v/v) D2O. For each sample, a
1H-15N-HSQC spectrum was acquired after an incubation period of 1 h. Since the
peak intensities did not change signiﬁcantly between 1 and 5 h, a 1 -h incubation
period was deemed sufﬁcient for reaching a quasi-stationary state.
Structure calculations of hPRLR-TMD. The assigned NOE peaks, dihedral angles
and hydrogen bonding restraints obtained for hPRLR-TMD were applied in a
standard simulated annealing protocol using Aria2 (version 2.3.2)34 and CNS35.
NOE peak intensities were calibrated and converted to inter-proton distances by
Aria2 during each iteration step using a distance cutoff of 6 Å. Each run consisted
of eight iterations, with 20 structures calculated in each of the ﬁrst seven. The seven
structures with lowest global energy were used as starting structures in the
subsequent iteration. The structure calculations were evaluated using the CcpNmr
Analysis software60 and the CING suite63. Iteratively, assignments were checked
manually, modiﬁed if needed, and structures recalculated. In the ﬁnal iteration, 200
structures were generated of which the 10 lowest energy structures without
signiﬁcant violations (Table 1) were selected to represent the monomeric structure
of hPRLR-TMD in DHPC micelles. The structures were visualized in PyMOL
(DeLano Scientiﬁc). Ramachandran-plot statistics for the structure ensemble
(residues 209–235) were calculated with PROCHECK64 and are as follows: most
favored (95.2%), additionally allowed (4.4%), generously allowed (0.4%) and
disallowed (0.0%).
Lipid interaction studies of hPRLR-D2. 1H-15N-HSQC spectra were acquired on
samples containing 50mM 15N-hPRLR-ECD-D2 in 10mM Na2HPO4, 10mM
TCEP, 2mM DSS and 10% D2O (pH 7.4) and no POPC SUVs or POPC SUVs at a
ﬁnal concentration of 8mM. Chemical shift differences and intensity ratios were
compared using the CcpNmr Analysis software60 to investigate possible
interactions between hPRLR-ECD-D2 and POPC.
SAXS and envelope generation. SAXS data on the monomeric hPRLR-
ECDQ1–D210 were recorded at the HESYLAB synchrotron in Hamburg, beam line
X33. Scattering was recorded at three different protein concentrations (1.15, 2.24
and 4.38mgml 1 in 10mM Na2HPO4 (pH 7.4)). The three scattering curves were
recorded in succession ﬂanked by recordings of the buffer background. A
high-quality scattering curve was constructed by merging the low-concentration
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data for low-scattering angles, intermediate concentration for intermediate-
scattering angles and data from the high concentration experiment for the highest
angle part of the scattering curve. The background sample consisted of the last
(pure protein sample) dialysis buffer after dialysis was completed. Data were
processed using the ATSAS package65. The theoretical scattering curve of the ECD
model (on the basis of PDB entry 3D48 (ref. 37)) was ﬁtted to the experimentally
determined envelope (w2¼ 1.22) (superposition performed in CRYSOL39, part of
the ATSAS package65) and the structure docked as a rigid body into the 3D density
map by using the ﬁt-in-map function from the UCSF CHIMERA66.
Relaxation measurements on hPRLR-ICDG236–Q396. Two series of 1H-15N-HSQC
spectra were recorded on 15N-hPRLR-ICDG236–Q396 to analyze the T1 and T2
relaxation times. 1H-15N-HSQC spectra were recorded at 750MHz (1H) and 4C
with delay times between 10 and 1,000ms (T1) and 10–250ms (T2) with two
triplicate measurements for each series. The relaxation decays were ﬁtted to single
exponentials and relaxation times determined using the CcpNmr Analysis
software60.
Oligomeric state and hydrodynamic radius of hPRLR-ICDG236–H598. 1H-15N-
HSQC spectra were recorded on 15N-hPRLR-ICDG236–H598 at 5C in 10% (v/v)
D2O, 8mM TCEP, 0.5mM DSS and 20mM Na2HPO4/NaH2PO4 (pH 7.3), at high
(400 mM) and low (20 mM) concentrations. Chemical shifts were compared using
the CcpNmr Analysis software60 to investigate the possibility of oligomerization.
The hydrodynamic radius of hPRLR-ICDG236–H598 was determined by PGSLED
NMR diffusion experiments using the pulse sequence of ref. 67. The experiments
were performed on 800mM 15N-hPRLR-ICD in 20mM Na2HPO4/NaH2PO4,
8mM TCEP, 0.5mM DSS in 90% (v/v) D2O (pH 7). As reference, 1.5mM
a-cyclodextrin under identical buffer and experimental conditions was used. All
spectra were recorded at 5 C on a Varian Inova 750MHz (1H) spectrometer. RH of
hPRLR-ICD was calculated from the relative diffusion decays of hPRLR-ICD and
a-cyclodextrin67, which has a RH of 7.52 Å (ref. 68).
Generation of FM ensemble. An ensemble of 1,000 models of the intrinsically
disordered hPRLR-ICD region (G236–H598) was generated with Flexible
Meccano40 using default options and without any restraints. We used the
HYDROPRO 10 (ref. 69) to predict the hydrodynamic properties (in particular the
hydrodynamic radius RH) of each of the members of the ensemble. These values
were averaged (asoRH 14 1) to estimate the value of RH our hPRLR-ICD
ensemble. The software was used with default options, and in short describes the
hydrodynamic properties of proteins by modelling the protein as a set of
overlapping spheres that in turn results in a shell-model of the protein69.
Structural model of the full hPRLR. The full structural model was assembled
through joining the individual domains at the overlapping sequences of the
structures. The overlapping regions were aligned and 1,000 model templates were
constructed from the three domains by building the longest model through
multiple independent cycles of reﬁnement in Modeller 9.15 (ref. 70). As starting
structures we used (1) a model of the unliganded ECD, which we built from the
X-ray structure of hPRLR-ECD in complex with prolactin (PDB entry 3MZG37,
removing the prolactin before the run) using Modeller 9.15., and which was
validated by comparing calculated and experimental SAXS curves using
CRYSOL39, (2) the NMR structure of hPRLR-TMD in micelles and (3) the FM
ensemble of hPRLR-ICD, which was validated by comparing calculated and
experimental RH values as described above. Each of the 1,000 assembled models
were subsequently reﬁned by a Modeller routine through multiple cycles of
conjugate gradient optimization (up to 100 steps each) optimizing the model with
the variable target function method, followed by molecular dynamics with
simulated annealing and a ﬁnal optimization with conjugate gradients using the
‘reﬁne.slow’ option of Modeller70. The ECD was oriented perpendicular to the
membrane surface, as no afﬁnity for POPC lipids was observed, while the TMD
was embedded in the sketch membrane in accordance with the DHPC-embedment
data. Finally, we discarded all conformations of the full-length hPRLR ensemble
model where the ICD folded back into regions occupied by the bilayer.
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